FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance
- PMID: 12028033
- DOI: 10.1046/j.1365-2141.2002.03429.x
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance
Abstract
The t(4:14) translocation affects two potential oncogenes, FGFR3 and MMSET, in multiple myeloma (MM). We investigated the frequency of FGFR3 dysregulation and its prognostic value in MM. FGFR3 mRNA levels were determined in 110 diagnostic bone marrow (BM) samples from MM patients. In addition, selected BM samples were screened for elevated MMSET mRNA levels. 14.5% (16/110) of MM BM samples showed dysregulated FGFR3 expression. Follow-up of 76 MM patients showed no significant difference between FGFR3 dysfunction and survival (P = 0.3) or correlation with known prognostic factors. Further, no linear relation was observed between FGFR3 and MMSET levels.
Comment in
-
t(4;14)(p16.3;q32) is strongly associated with a shorter survival in myeloma patients.Br J Haematol. 2003 Jan;120(1):170-1. doi: 10.1046/j.1365-2141.2003.03983_5.x. Br J Haematol. 2003. PMID: 12492597 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
